FTRE
Price
$18.27
Change
-$0.04 (-0.22%)
Updated
Aug 25 closing price
Capitalization
1.74B
72 days until earnings call
Intraday BUY SELL Signals
MRVI
Price
$9.00
Change
+$0.57 (+6.76%)
Updated
Aug 25 closing price
Capitalization
1.25B
72 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FTRE vs MRVI

FTRE vs MRVI Comparison Chart in %
View a ticker or compare two or three
VS
FTRE vs. MRVI commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a StrongBuy and MRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2026
Stock price -- (FTRE: $18.31 vs. MRVI: $8.43)
Brand notoriety: FTRE and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 66% vs. MRVI: 196%
Market capitalization -- FTRE: $1.74B vs. MRVI: $1.25B
FTRE [@Biotechnology] is valued at $1.74B. MRVI’s [@Biotechnology] market capitalization is $1.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, both FTRE and MRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while MRVI’s TA Score has 6 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 5 bearish.
  • MRVI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +1.16% price change this week, while MRVI (@Biotechnology) price change was +48.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.36%. For the same industry, the average monthly price growth was +10.69%, and the average quarterly price growth was +3048.31%.

Reported Earning Dates

FTRE is expected to report earnings on Nov 05, 2026.

MRVI is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+3.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.74B) has a higher market cap than MRVI($1.25B). MRVI YTD gains are higher at: 159.385 vs. FTRE (6.145). FTRE has higher annual earnings (EBITDA): 84.7M vs. MRVI (-104.31M). FTRE (169M) and MRVI (166M) have equal amount of cash in the bank . MRVI has less debt than FTRE: MRVI (271M) vs FTRE (1.12B). FTRE has higher revenues than MRVI: FTRE (2.68B) vs MRVI (205M).
FTREMRVIFTRE / MRVI
Capitalization1.74B1.25B139%
EBITDA84.7M-104.31M-81%
Gain YTD6.145159.3854%
P/E RatioN/AN/A-
Revenue2.68B205M1,305%
Total Cash169M166M102%
Total Debt1.12B271M413%
TECHNICAL ANALYSIS
Technical Analysis
FTREMRVI
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signal:
Gain/Loss:
MRVI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOVZ33.730.40
+1.20%
iShares 25+ Year Treasury STRIPS Bd ETF
IAI194.760.23
+0.12%
iShares US Broker-Dealers&Secs Exchs ETF
SOLT35.73N/A
N/A
2X Solana ETF
AVMA73.84-0.12
-0.17%
Avantis Moderate Allocation ETF
QSIX41.85-0.36
-0.85%
Pacer Metarus Nasdaq 100 Div Mltpl600ETF

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with RXRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-0.44%
RXRX - FTRE
40%
Loosely correlated
-7.14%
BEAM - FTRE
39%
Loosely correlated
-4.81%
NTLA - FTRE
37%
Loosely correlated
-2.18%
CRSP - FTRE
35%
Loosely correlated
-4.08%
RAPP - FTRE
32%
Poorly correlated
+2.26%
More